Adams RD, Victor M, Ropper AH: Principles of Neurology, 6th Ed, McGraw-Hill, New York, 1997..
Sidey JD: Weak ankles: a study of common peroneal entrapment neuropathy. .BMJ 3::623. ,1969. .
Sunderland S: Nerves and Nerve Injuries, 2nd Ed, Churchill Livingstone, Edinburgh, 1978..
Koller RL, Blank NK: Strawberry picker’s palsy. .Arch Neurol 37::320. ,1980. .
Sotaniemi KA: Slimmer’s paralysis–peroneal neuropathy during weight reduction. .J Neurol Neurosurg Psychiatry 47::564. ,1984. .
Heffernan LPM: Electromyographic value of the tibialis posterior muscle. .Arch Phys Med Rehabil 60::170. ,1979. .
Pickett JB: Localizing peroneal nerve lesions to the knee by motor conduction studies. .Arch Neurol 41::192. ,1984. .
Marinacci AA: Neurological syndromes of the tarsal tunnels. .Bull Los Angeles Neurol Soc 33::90. ,1968. .
Krause KH, Witt T, Ross A: The anterior tarsal tunnel syndrome. .J Neurol 217::67. ,1977. .
Ruprecht EO: “Befunde bei Neuropathien,” in Electromyographie, ed by HC Hopf, A Struppler, p 37, Georg Thieme Verlag, Stuttgart, 1974..
Falck B, Alaranta H: Fibrillation potentials, positive sharp waves and fasciculation in the intrinsic muscles of the foot in healthy subjects. .J Neurol Neurosurg Psychiatry 46::681. ,1983. .
Gatens PF, Saeed MA: Electromyographic findings in the intrinsic muscles of normal feet. .Arch Phys Med Rehabil 63::317. ,1982. .
Rubin M, Menche D, Pitman M: Entrapment of an accessory superficial peroneal sensory nerve. .Can J Neurol Sci 18::342. ,1991. .
Goodgold J, Kopell HP, Spielholz NI: The tarsal-tunnel syndrome: objective diagnostic criteria. .N Engl J Med 273::742. ,1965. .
Keck C: The tarsal-tunnel syndrome. .J Bone Joint Surg Am 44::180. ,1962. .
Mann RA: Tarsal tunnel syndrome. .Orthop Clin North Am 5::109. ,1974. .
MacFarlane IJA, Du Toit SN: A ganglion causing tarsal tunnel syndrome. .S Afr Med J 48::2568. ,1974. .
Wiles CM, Whitehead S, Ward AB, et al: Not tarsal tunnel syndrome: malignant “triton” tumour of the tibial nerve. .J Neurol Neurosurg Psychiatry 50::479. ,1987. .
Oh SJ, Kim HS, Ahmad BK: The near-nerve sensory nerve conduction in tarsal tunnel syndrome. .J Neurol Neurosurg Psychiatry 48::999. ,1985. .
Guiloff RJ, Sherratt RM: Sensory conduction in medial plantar nerve: normal values, clinical applications, and a comparison with the sural and upper limb sensory nerve action potentials in peripheral neuropathy. .J Neurol Neurosurg Psychiatry 40::1168. ,1977. .
Oh SJ, Sarala PK, Kuba T, et al: Tarsal tunnel syndrome: electrophysiological study. .Ann Neurol 5::327. ,1979. .
Nakano KK: The entrapment neuropathies. .Muscle Nerve 1::264. ,1978. .
Dyck PJ, Lambert EH, Nichols PC: “Quantitative Measurement of Sensation Related to Compound Action Potential and Number and Size of Myelinated Fibers of Sural Nerve in Health, Friedrich’s Ataxia, Hereditary Sensory Neuropathy and Tabes Dorsalis,” in Handbook of Electroencephalography and Clinical Neurophysiology, Vol 9, ed by A Remond, p 83, Elsevier, Amsterdam, 1971..
Gross JA, Hamilton WJ, Swift TR: Isolated mechanical lesions of the sural nerve. .Muscle Nerve 3::248. ,1980. .
Schuchmann JA: Isolated sural neuropathy: report of two cases. .Arch Phys Med Rehabil 61::329. ,1985. .
Ertekin C: Saphenous nerve conduction in man. .J Neurol Neurosurg Psychiatry 32::530. ,1969. .
Senden R, Van Mulders J, Ghys R, et al: Conduction velocity of the distal segment of the saphenous nerve in normal adult subjects. .Electromyogr Clin Neurophysiol 21::3. ,1981. .
Stohr M, Schumm F, Ballier R: Normal sensory conduction in the saphenous nerve in man. .Electroencephalogr Clin Neurophysiol 44::172. ,1978. .
Kopell HP, Thompson WAL: Peripheral Entrapment Neuropathies, 2nd Ed, Robert E. Krieger, Huntington, NY, 1976..
Wall PD, Melzack R (eds): Textbook of Pain, Churchill Livingstone, Edinburgh, 1994..
Stanton-Hicks M, Janig W, Hassenbusch S, et al: Reflex sympathetic dystrophy: changing concepts and taxonomy. .Pain 63::127. ,1995. .
Canale DJ: Civil war medicine from the perspective of S. Weir Mitchell’s “The case of George Dedlow.”. J Hist Neurosci 11::11. ,2002. .
Veldman PHJM, Reynen HM, Ivo EA, et al: Signs and symptoms of reflex sympathetic dystrophy: prospective study of 829 patients. .Lancet 342::1012. ,1993. .
Ochoa JL: Essence, investigation and management of “neuropathic” pains: hopes from acknowledgment of chaos. .Muscle Nerve 16::997. ,1993. .
Ramamurthy S, Hoffman J, the Guanethidine Study Group: Intravenous regional guanethidine in the treatment of reflex sympathetic dystrophy/causalgia: a randomized, double-blind study. .Anesth Analg 81::718. ,1995. .
Schott GD: An unsympathetic view of pain. .Lancet 345:: 634. ,1995. .
Willner C, Low PA: “Pharmacologic Approaches to Neuropathic Pain,” in Peripheral Neuropathy, 3rd Ed, ed by PJ Dyck, PK Thomas, JW Griffin, et al, p 1709, WB Saunders, Philadelphia, 1993..
Landau B, Levy RM: Neuromodulation techniques for medically refractory chronic pain. .Annu Rev Med 44:: 279. ,1993. .
Bradley WG, Daroff RB, Fenichel GM, et al: Neurology in Clinical Practice: Principles of Diagnosis and Management, 3rd Ed, p 368, Butterworth Heinemann, Newton, MA, 2000..
American Heart Association: 1998 Heart and Stroke Statistical Update, American Heart Association, Dallas, 1997..
Goetz CG: Textbook of Clinical Neurology, p 237, WB Saunders, Philadelphia, 1999..
Canale ST: Campbell’s Operative Orthopaedics, 10th Ed, p 1265, CV Mosby, St Louis, 2003..
Takahashi S, Shrestha A: The vulpus procedure for correction of equinus deformity in patients with hemiplegia. .J Bone Joint Surg Br 84::978. ,2002. .
Ozonoff MB: “The Foot,” in Pediatric Orthopedic Radiology, ed by MB Ozonoff, p 397, WB Saunders, Philadelphia, 1992..
Hesse S, Krajnic J, Lueckne D, et al: Ankle muscle activity before and after botulinum toxin therapy for lower limb extensor spasticity in chronic hemiparetic patients. .Stroke 27::455. ,1996. .
Koman LA, Mooney JF III, Smith BP, et al: Botulinum toxin type A neuromuscular blockade in the treatment of lower extremity spasticity in cerebral palsy: a randomized, double-blind, placebo-controlled trial. .J Pediatr Orthop 20::108. ,2000. .
Koman LA, Brashear A, Rosenfeld S, et al: Botulinum toxin type A neuromuscular blockade in the treatment of equinus foot deformity in cerebral palsy: a multicenter, open-label clinical trial. .Pediatrics 108::1062. ,2001. .
Graham HK, Selber P: Musculoskeletal aspects of cerebral palsy. .J Bone Joint Surg Br 85::157. ,2000. .
Kuban KCK, Leviton A: Medical progress: cerebral palsy. .N Engl J Med 330::188. ,1994. .
Nelson KB, Ellenberg JH: Antecedents of cerebral palsy: multivariate analysis of risk. .N Engl J Med 315:: 81. ,1986. .
Tardieu G, Tardieu C: Cerebral palsy: mechanical evaluation and conservative correction of limb joint contractures. .Clin Orthop 219::63. ,1987. .
Cottalorda J, Gautheron V, Metton G, et al: Toe-walking in children younger than six years with cerebral palsy: the contribution of serial corrective casts. .J Bone Joint Surg Br 82::541. ,2000. .
Goldberg MJ: Botulinum toxin type A improved ankle function in children with cerebral palsy and dynamic equinus foot deformity. .J Bone Joint Surg Am 82::874. ,2000. .
Bennett FC, Crowe T, Deitz J, et al: Childhood motor skills in premature infants. Paper presented at the annual meeting of the American Academy of Cerebral Palsy and Developmental Medicine, Washington, DC, October 1984..
Rosenbloom L: Diagnosis and management of cerebral palsy. .Arch Dis Child 72::350. ,1995. .
Podiatric physicians care for a wide spectrum of patients with neurologic illness. Often, patients with neurologic disease present to their podiatric physician with unrelated complaints that can be easily separated from their underlying neurologic condition. However, some neurologic conditions predictably lead to podiatric disease and, as such, are best treated in the context of the broader disease process. Neuropathies, spastic disorders, and cerebral palsy are examples of common neurologic disorders that can be associated with substantial podiatric manifestations; therefore, it is important for podiatric physicians to be familiar with these conditions. This article reviews the pathophysiology, clinical manifestations, and management of the common neurologic disorders affecting the foot. (J Am Podiatr Med Assoc 94(2): 104-117, 2004)